My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

IQVIA Holdings, Inc. Common Stock (NY:IQV)

206.63 +2.29 (+1.12%)
Official Closing Price Updated: 7:00 PM EDT, Oct 3, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about IQVIA Holdings, Inc. Common Stock

< Previous 1 2
...
8 9 10 11 12 13 14 15 Next >
The Latest Analyst Ratings for IQVIA Hldgs
 
Via Benzinga
$100 Invested In This Stock 5 Years Ago Would Be Worth $200 Today
 
Via Benzinga
Here's How Much You Would Have Made Owning IQVIA Hldgs Stock In The Last 5 Years
 
Via Benzinga
2 Clinical Research Stocks That Could Grow by More Than 10% This Year, and 1 to Watch
These companies strive to bring down the cost of developing new therapies. 
Via The Motley Fool
(IQV) - Analyzing IQVIA Hldgs's Short Interest
 
Via Benzinga
What 6 Analyst Ratings Have To Say About IQVIA Hldgs
 
Via Benzinga
Global Clinical Trial Activity Remained Resilient in 2022 Despite The Continued Pandemic, Says IQVIA Institute
From IQVIA
Via Business Wire
Here's How Much $100 Invested In IQVIA Hldgs 5 Years Ago Would Be Worth Today
 
Via Benzinga
Where IQVIA Hldgs Stands With Analysts
 
Via Benzinga
IQVIA Clocks 2.8% Sales Growth In Q4, Beats Street View By A Whisker
 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 17, 2023
 
Via Benzinga
IQVIA CFO Ron Bruehlman to Speak at Barclays Global Healthcare Conference on March 15, 2023
From IQVIA
Via Business Wire
MannKind To Rally Around 30%? Here Are 10 Other Analyst Forecasts For Monday
Piper Sandler cut the price target for CS Disco, Inc. (NYSE: LAW) from $11 to $7.5. Piper Sandler analyst Arvind Ramnani downgraded the stock from Overweight to Neutral. CS Disco shares fell 1.2% to... 
Via Benzinga
Earnings Outlook For IQVIA Holdings
 
Via Benzinga
Will Investors Notice Exciting Sign On IQVIA Hldgs's Chart?
 
Via Benzinga
Analyst Ratings for IQVIA Hldgs
 
Via Benzinga
IQVIA Publishes its 2022 Environmental, Social and Governance Report
From IQVIA
Via Business Wire
Got $300? 3 Growth Stocks to Buy That Could Double Your Money
All three companies have shown consistent revenue and EPS growth. 
Via The Motley Fool
7 Hot Healthcare Stocks With the Potential to Outperform
These healthcare stocks to buy now have the potential to outperform the market over the long-term because their businesses are strong. 
Via InvestorPlace
IQVIA Reports Fourth-Quarter and Full-Year 2022 Results; Issues Full-Year 2023 Guidance
From IQVIA Holdings Inc.
Via Business Wire
PayPal, Global Payments And 3 Stocks To Watch Heading Into Friday
With US futures trading mixed this morning on Friday, some of the stocks that may grab investor focus today are as follows: 
Via Benzinga
Investor Optimism Declines Slightly As Dow Drops 250 Points
The CNN Money Fear and Greed index showed some decline in the overall sentiment among US investors. US stocks closed lower on Thursday as investors assessed recent batch of corporate earnings. 
Via Benzinga
IQVIA Named to FORTUNE’s 2023 List of “World’s Most Admired Companies,” Ranked #1 in Its Category for the Second Consecutive Year
From IQVIA
Via Business Wire
3 Revolutionary Stocks I'd Buy Right Now Without Hesitation
These companies are changing their industries. 
Via The Motley Fool
IQVIA in Collaboration with Alibaba Cloud to Deliver Commercial & Clinical Solutions in China
From IQVIA
Via Business Wire
IQVIA to Announce Fourth-Quarter and Full-Year 2022 Results on February 10, 2023
From IQVIA
Via Business Wire
Global Market for Medicines to Rise to $1.9 Trillion by 2027, says Report from IQVIA Institute
From IQVIA
Via Business Wire
World Wrestling Entertainment To Rally Around 12%? Here Are 10 Other Analyst Forecasts For Tuesday
Goldman Sachs boosted the price target for The Wendy's Company (NASDAQ: WEN) from $22 to $25. Goldman Sachs analyst Jared Garber maintained a Neutral rating on the stock. Wendy's shares fell 1.4% to... 
Via Benzinga
2 Unstoppable Growth Stocks to Buy in 2023 and Beyond
These healthcare companies' revenue and earnings have grown, and they expect more growth. 
Via The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For December 6, 2022
 
Via Benzinga
< Previous 1 2
...
8 9 10 11 12 13 14 15 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.